| |
| |
|
| Insider
Information: |
Shue Youe Kong |
| Relationship: |
VP, Clinical Development |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
94,230 |
|
|
Indirect Shares
|
5,538 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
99,768 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Optimer Pharmaceuticals Inc |
OPTR |
VP, Clinical Development |
2011-11-15 |
94,230 |
2007-02-14 |
5,538 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2011-11-15 |
4 |
A |
$9.72 |
$11,533 |
D/D |
1,186 |
94,230 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2011-05-16 |
4 |
A |
$7.71 |
$11,441 |
D/D |
1,484 |
93,044 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2010-11-15 |
4 |
A |
$7.71 |
$11,202 |
D/D |
1,453 |
91,560 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2010-08-30 |
4 |
OE |
$1.08 |
$11,510 |
D/D |
6,298 |
90,107 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2010-05-17 |
4 |
A |
$9.57 |
$11,112 |
D/D |
1,161 |
83,809 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2009-12-02 |
4 |
B |
$10.89 |
$21,855 |
D/D |
2,000 |
82,648 |
2.74 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2009-12-01 |
4 |
B |
$11.10 |
$11,100 |
D/D |
1,000 |
80,648 |
2.74 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, clinical Development |
• – – |
2009-11-16 |
4 |
A |
$9.91 |
$10,862 |
D/D |
1,096 |
79,648 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2009-05-15 |
4 |
A |
$7.23 |
$10,772 |
D/D |
1,491 |
78,552 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP Clinical Development |
• – – |
2008-11-17 |
4 |
B |
$6.18 |
$10,499 |
D/D |
1,699 |
77,061 |
2.74 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2008-05-15 |
4 |
B |
$6.04 |
$10,398 |
D/D |
1,723 |
75,362 |
2.74 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP Clinical Development |
• – – |
2007-11-15 |
4 |
B |
$5.95 |
$5,950 |
D/D |
1,000 |
75,485 |
2.74 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP Clinical Development |
• – – |
2007-08-10 |
4 |
B |
$8.24 |
$16,572 |
D/D |
2,000 |
74,485 |
2.74 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP Clinical Development |
• – – |
2007-08-09 |
4 |
B |
$8.30 |
$4,150 |
D/D |
500 |
72,485 |
2.66 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical Development |
• – – |
2007-02-14 |
4 |
A |
$0.00 |
$0 |
I/I |
5,538 |
5,538 |
0 |
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP, Clinical DevelopmentOffice |
• – – |
2007-02-08 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
56,294 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP Clinical DevelopmentOfficer |
• – – |
2007-02-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
20,306 |
|
- |
|
| OPTR |
Optimer Pharmaceuticals I... |
VP Clinical DevelopmentOfficer |
• – – |
2007-02-08 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
58,140 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
